Testing boundaries of post-vaccination life

March 29, 2021
A clinical trial at U.S. college campuses, co-led by Dr. Audrey Pettifor, will test if COVID-19 vaccines prevent the spread of SARS-CoV-2.

Communicating a crisis

March 24, 2021
During Carolina's Pandemic Year, when University communicators needed to get lifesaving messages to students and employees, they called on top public health experts who also happen to be Carolina faculty.

Tucker, Lo represent Gillings School as MLK Scholarship finalists

March 20, 2021
Two undergraduate students represented the Gillings School in the running for the 2021 Martin Luther King Jr. Scholarship at UNC-Chapel Hill. Aneesha Tucker was the scholarship winner, receiving $2,000. Amy Lo was one of two runners-up, earning $1,500.

Courtney Woods and the case of the contaminated current

February 25, 2021
Leaders from the Sampson County community in North Carolina welcomed Assistant Professor Dr. Courtney Woods into their local environmental justice efforts.

New dashboard estimates number of NC residents eligible for each vaccine phase

February 23, 2021
As North Carolina prepares to enter Phase 3 of COVID-19 vaccine distribution, the North Carolina Institute for Public Health has created a set of dashboards to assist local planning by providing valid population estimates for the phased distribution of the vaccine in the state.

Remembering Joan Gillings, who inspired thousands with her ‘can do, hands on’ approach

February 22, 2021
Joan Gillings passed away on February 18. Her name and her spirit will live on in the Gillings School of Global Public Health. “Joan was a force of nature, a wonderful leader in North Carolina and beyond,” says Dean Barbara K. Rimer.

Diggs appointed Director of Diversity, Equity and Inclusion at Blue Cross and Blue Shield of North Carolina

February 19, 2021
Pam Diggs has been named Director of Diversity, Equity and Inclusion at insurer Blue Cross and Blue Shield of North Carolina.

Broad spectrum antiviral proves highly effective at preventing, treating COVID-19 infection

February 9, 2021
Using a novel in vivo research model containing human lung tissue, UNC Gillings School of Global Public Health and UNC School of Medicine scientists demonstrated that the experimental drug EIDD-2801 proved dramatically effective at preventing and treating SARS-CoV-2 infection.

Graduate student ‘Boundary Spanners’ help NC communities address COVID-19 challenges

February 2, 2021
UNC-Chapel Hill faculty and graduate students created the I4 Boundary Spanners program to address local COVID-19 concerns by combining data analysis with firsthand community perspectives.

LaVange appointed chair of Department of Biostatistics

February 1, 2021
Dr. Lisa LaVange has been appointed to the position of chair of the Department of Biostatistics at the UNC Gillings School of Global Public Health.